P
2018
Proteins and Peptides are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases, which can be administered orally are known as oral peptide and ...
Report Code : A00285 | Pages : 120 | Category : Life Sciences
P
2021
The global liver disease treatment market size was valued at $20,673.70 million in 2020, and is estimated to reach $36,455.70 million by 2030, growing at a CAGR of ...
Report Code : A00295 | Pages : 254 | Category : Life Sciences
P
2019
The global antihypertensive market accounted for $22,557 million in 2018, and is expected to reach $28,797 million by 2026, registering a CAGR of 3.1% from 2019 to 2026.
Report Code : A00337 | Pages : 222 | Category : Life Sciences
P
2022
The global aneurysmal subarachnoid hemorrhage drugs market was valued at $323.51 million in 2020, and is projected to reach $456.31 million by 2030, growing at a CAGR of 3.6% from 2021 to 2030.
Report Code : A04249 | Pages : 180 | Category : Life Sciences
P
2017
The Germany IVD market accounted for $3,727 million in 2016, and is estimated to reach at $5,453 million by 2023, growing at a CAGR of 5.5% from 2017 ...
Report Code : A03791 | Pages : 140 | Category : Life Sciences
P
2017
The LAMEA IVD market accounted for $7,413 million in 2016, and is estimated to reach $10,316 million by 2023, growing at a CAGR of 4.7% from 2017 to ...
Report Code : A03790 | Pages : 174 | Category : Life Sciences
P
2017
The North America IVD market is accounted for $20,886 million in 2016, and is estimated to reach $27.820 million by 2023, growing at a CAGR of 4.1% during the analysis period 2017-2023.
Report Code : A03999 | Pages : 174 | Category : Life Sciences
P
2022
The global transdermal drug delivery systems market size was $52,476.50 million in 2020, and is projected to reach $87,322.40 million by 2030, growing at a CAGR of 4.9% from 2021 to 2030.
Report Code : A00385 | Pages : 175 | Category : Life Sciences
P
2022
The global contraceptives market was valued at $26,321.50 million in 2020, and is projected to reach $50,595.8 million by 2030, growing at a CAGR of 6.5% from 2021 to 2030.
Report Code : A00352 | Pages : 192 | Category : Life Sciences
P
2014
Ebola virus disease (EVD), also known as Ebola hemorrhagic fever (EHF), results from Ebola virus and three other closely related viruses in the genes (group of related viruses) ...
Report Code : A00402 | Pages : 55 | Category : Life Sciences
Register and Earn 500 Loyalty Points
An Email Verification Code has been sent to your email address!
Please check your inbox and, if you don't find it there, also look in your junk folder.